Navigation Links
New Finding Suggests Safe Surgical Margins When Removing Breast Cancers
Date:10/21/2010

THURSDAY, Oct. 21 (HealthDay News) -- A new study suggests that in women undergoing breast-conserving surgery, removing at least 2 millimeters of healthy tissue in addition to a cancerous breast tumor is enough to lower the risk of residual cancer.

Surgeons disagree about how much of a "free margin" around a tumor is ideal, according to the study, which appears online in the November issue of IJCP, the International Journal of Clinical Practice. In the United Kingdom, about two-thirds of surgeons surveyed said they prefer a margin of 2 millimeters or more, while nearly a quarter favor removing only 1 millimeter.

"The issue is that whenever you take a lump out of someone's breast, you want to have some normal tissue around the entire malignancy. That's how the surgeon can make the statement that 'I think I got the whole thing,'" said Dr. Otis Brawley, chief medical officer of the American Cancer Society.

Surgeons often perform a procedure again if they don't think the margins are large enough, Brawley said.

In the new study, researchers from Good Hope Hospital in West Midland, U.K., examined the medical records of 303 breast cancer patients undergoing breast conservation therapy to remove a cancerous lump. They found that 44 percent underwent follow-up surgery because the margins around the tumors were less than 5 millimeters and considered too small. Upon examination of the excised tissues, however, only about 2 percent of those with margins of 2 millimeters or more showed signs of residual cancer.

This meant that with a free margin of 2 millimeters or more, 98 percent of the patients showed no signs of residual cancer, the researchers said.

In addition, they found that the amount of residual disease decreased as the margin increased: 35.3 percent of the women who underwent surgery for invasive breast cancer had residual cancer with no margin, compared to 2.4 percent with a margin of more than 2 millimeters.

"Our results clearly show a relationship between the width of the free margin and the likelihood of finding residual disease at further surgery," the researchers wrote. "To minimize the risk of residual disease, we would recommend aiming for a free margin from invasive tumor of 2 millimeters."

However, the study authors noted that the findings did not apply to women with a precancerous condition known as ductal carcinoma in situ (DCIS). One-third of the patients with DCIS had residual disease even with a free margin up to 5 millimeters. "The equivalent free margin for DCIS remains unknown," they wrote.

Brawley said surgeons may someday embrace 2-millimeter margins around malignant tumors and perform fewer follow-up surgeries as a result. "But it'll be a while before people gravitate to it," he said.

More information

The U.S. National Library of Medicine has more on breast cancer.

-- Randy Dotinga

SOURCE: International Journal of Clinical Practice, Oct. 20, 2010; Otis Brawley, M.D., chief medical officer, American Cancer Society; press release, Oct. 18,


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. $4.37 million NCI grant accelerates recent laboratory finding in Ewings sarcoma
2. Encouraging findings suggest new avenues for treating liver disease in overweight Americans
3. Latest Findings Back Mammograms for Women in Their 40s
4. National committee releases findings on transforming and improving the nursing profession
5. Study findings show value of dietary supplement SAMe in treatment of adults with major depressive disorders
6. Scientists closer to finding what causes the birth of a fat cell
7. New findings further clarify breast cancer risk with hormone therapy
8. Mayo Clinic researchers share latest findings in CT radiation dose reduction efforts
9. U. Iowa biologists publish findings on cell interactions
10. Strong scientific findings presented at AIDS 2010 point to promise ahead and underscore the need to stay the course
11. Tel Aviv University Fertility Research Confirms New York Center's DHEA Findings
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Finding Suggests Safe Surgical Margins When Removing Breast Cancers
(Date:6/24/2016)... ... June 24, 2016 , ... Advanced ... 2016 Miss Arizona pageant as its official Medspa Sponsor. Dr. Josh Olson, a ... Chandler, Arizona. , Dr. Olson says the decision to support the pageant ...
(Date:6/24/2016)... ... June 24, 2016 , ... Southern Illinois ... are co-chairs for the Illinois State Dental Society (ISDS) Foundation’s Mission of Mercy ... Gateway Convention Center in Collinsville. , They expect to treat approximately ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Seema Daulat, a native Texan and ... South Lamar location as of July 13, 2016. , Dr. Daulat earned her Doctorate ... student, she regularly volunteered at the Agape Clinic serving Dallas’ underprivileged community. , Following ...
(Date:6/23/2016)... ... June 23, 2016 , ... vcfo, a ... support, is pleased to announce the promotion of Mike Mackey to Regional Vice ... Manager where he was responsible for managing client projects and overseeing vcfo financial ...
(Date:6/23/2016)... ... 23, 2016 , ... Virginia Beach resident Sean Kelly suffered from depression after ... to find peace and set out to accomplish a personal mission: a solo 50-mile ... internet. He came across the story of another special operations veteran, Josh Collins, whom ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM ... sells medical devices and wearable sleep respiratory products in ... agreement with Hongyuan Supply Chain Management Co., Ltd. (hereinafter ... 2016, to develop Dehaier,s new Internet medical technology business. ... leverage Hongyuan Supply Chain,s sales platform to reach Dehaier,s ...
(Date:6/24/2016)... According to a new market ... Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, ... of Purchase (Retail, Non-Retail) - Trends & Global Forecasts ... market for the forecast period of 2016 to 2021. ... by 2021 from USD 1.65 Billion in 2016, growing ...
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: